APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 249 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,245 | -37.7% | 1,426 | +49.2% | 0.00% | -33.3% |
| Q2 2023 | $87,092 | +40.2% | 956 | +1.5% | 0.00% | +50.0% |
| Q1 2023 | $62,134 | +1523.6% | 942 | +1173.0% | 0.00% | – |
| Q4 2022 | $3,827 | -36.2% | 74 | -8.6% | 0.00% | – |
| Q3 2022 | $6,000 | +100.0% | 81 | +9.5% | 0.00% | – |
| Q2 2022 | $3,000 | -50.0% | 74 | -43.1% | 0.00% | – |
| Q1 2022 | $6,000 | 0.0% | 130 | -1.5% | 0.00% | – |
| Q4 2021 | $6,000 | +200.0% | 132 | +123.7% | 0.00% | – |
| Q3 2021 | $2,000 | -50.0% | 59 | 0.0% | 0.00% | – |
| Q2 2021 | $4,000 | +33.3% | 59 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | 0.0% | 59 | 0.0% | 0.00% | – |
| Q4 2020 | $3,000 | 0.0% | 59 | -46.4% | 0.00% | – |
| Q3 2020 | $3,000 | -40.0% | 110 | -29.0% | 0.00% | – |
| Q2 2020 | $5,000 | – | 155 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |